| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-163 |
Sentence |
denotes |
Lack of association of C-C chemokine receptor 5 Δ32 deletion status with rheumatoid arthritis, systemic lupus erythematosus, lupus nephritis, and disease severity. |
| T1 |
0-163 |
Sentence |
denotes |
Lack of association of C-C chemokine receptor 5 Δ32 deletion status with rheumatoid arthritis, systemic lupus erythematosus, lupus nephritis, and disease severity. |
| T2 |
164-247 |
Sentence |
denotes |
OBJECTIVE: C-C chemokine receptor 5 (CCR5) plays an important role in inflammation. |
| T2 |
164-247 |
Sentence |
denotes |
OBJECTIVE: C-C chemokine receptor 5 (CCR5) plays an important role in inflammation. |
| T3 |
248-329 |
Sentence |
denotes |
A 32 base-pair (Δ32) deletion in the CCR5 gene leads to a nonfunctional receptor. |
| T3 |
248-329 |
Sentence |
denotes |
A 32 base-pair (Δ32) deletion in the CCR5 gene leads to a nonfunctional receptor. |
| T4 |
330-456 |
Sentence |
denotes |
This deletion has been reported to have a protective effect on the development and progression of several autoimmune diseases. |
| T4 |
330-456 |
Sentence |
denotes |
This deletion has been reported to have a protective effect on the development and progression of several autoimmune diseases. |
| T5 |
457-713 |
Sentence |
denotes |
We investigated whether the Δ32 deletion is associated with disease susceptibility in a population of patients with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and lupus nephritis (LN); and whether it is associated with disease severity. |
| T5 |
457-713 |
Sentence |
denotes |
We investigated whether the Δ32 deletion is associated with disease susceptibility in a population of patients with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and lupus nephritis (LN); and whether it is associated with disease severity. |
| T6 |
714-857 |
Sentence |
denotes |
METHODS: DNA samples from 405 RA patients, 97 SLE patients, 113 LN patients, and 431 healthy controls were genotyped for the CCR5 Δ32 deletion. |
| T6 |
714-857 |
Sentence |
denotes |
METHODS: DNA samples from 405 RA patients, 97 SLE patients, 113 LN patients, and 431 healthy controls were genotyped for the CCR5 Δ32 deletion. |
| T7 |
858-936 |
Sentence |
denotes |
Differences in genotype frequencies were tested between patients and controls. |
| T7 |
858-936 |
Sentence |
denotes |
Differences in genotype frequencies were tested between patients and controls. |
| T8 |
937-997 |
Sentence |
denotes |
Association of genotypes with disease severity was analyzed. |
| T8 |
937-997 |
Sentence |
denotes |
Association of genotypes with disease severity was analyzed. |
| T9 |
998-1006 |
Sentence |
denotes |
RESULTS: |
| T9 |
998-1006 |
Sentence |
denotes |
RESULTS: |
| T10 |
1007-1077 |
Sentence |
denotes |
Genotype frequencies of each group were in Hardy-Weinberg equilibrium. |
| T10 |
1007-1077 |
Sentence |
denotes |
Genotype frequencies of each group were in Hardy-Weinberg equilibrium. |
| T11 |
1078-1275 |
Sentence |
denotes |
The genotype frequencies of patients did not differ significantly from controls (CCR5/Δ32, Δ32/Δ32: RA 18.3% and 1.2%, respectively; SLE 17.5% and 2.1%; LN 13.3% and 1.8%; controls 20.0% and 2.8%). |
| T11 |
1078-1275 |
Sentence |
denotes |
The genotype frequencies of patients did not differ significantly from controls (CCR5/Δ32, Δ32/Δ32: RA 18.3% and 1.2%, respectively; SLE 17.5% and 2.1%; LN 13.3% and 1.8%; controls 20.0% and 2.8%). |
| T12 |
1276-1390 |
Sentence |
denotes |
However, there was a trend for lower Δ32 deletion allele frequency in LN patients compared to controls (p = 0.08). |
| T12 |
1276-1390 |
Sentence |
denotes |
However, there was a trend for lower Δ32 deletion allele frequency in LN patients compared to controls (p = 0.08). |
| T13 |
1391-1491 |
Sentence |
denotes |
There was no significant association between the CCR5 status and disease severity in RA, SLE, or LN. |
| T13 |
1391-1491 |
Sentence |
denotes |
There was no significant association between the CCR5 status and disease severity in RA, SLE, or LN. |
| T14 |
1492-1503 |
Sentence |
denotes |
CONCLUSION: |
| T14 |
1492-1503 |
Sentence |
denotes |
CONCLUSION: |
| T15 |
1504-1651 |
Sentence |
denotes |
Although an association with LN cannot be excluded, the CCR5 Δ32 deletion does not seem to be a disease susceptibility genotype for RA, SLE, or LN. |
| T15 |
1504-1651 |
Sentence |
denotes |
Although an association with LN cannot be excluded, the CCR5 Δ32 deletion does not seem to be a disease susceptibility genotype for RA, SLE, or LN. |
| T16 |
1652-1731 |
Sentence |
denotes |
No significant effect of the Δ32 deletion on disease severity was demonstrated. |
| T16 |
1652-1731 |
Sentence |
denotes |
No significant effect of the Δ32 deletion on disease severity was demonstrated. |